Epidemiology of STD & Infectious Diseases

Since 1993, STI epidemiology and management have evolved interactively, particularly in developing countries. Technological advances in diagnosis, screening, and treatment; evaluation and widespread implementation of new case-management algorithms; and changes in risk behaviors in response to the AIDS epidemic have all influenced the dynamic typology of STIs. Every year worldwide, there are approximately 357 million new infections of syphilis, chlamydia, gonorrhea, and trichomoniasis. A major recent advance in STI prevention is the early success of a prophylactic, monovalent human papillomavirus (HPV) type 16 vaccine, HPV vaccines may be able to help prevent genital and anal cancers in the foreseeable future.

  • Syndromic Management
  • Role of Core Groups
  • Antibiotic Use
  • Drug Resistance
  • Sexual Health Care
  • Social Risk Markers
  • Behavioral Risk Factors
  • Clinical interventions 

Related Conference of Epidemiology of STD & Infectious Diseases

August 21-23, 2017

3rd Annual Congress on Infectious Diseases

San Francisco, California, USA
September 04-05, 2017

Global Experts Meeting on Sexually Transmitted Diseases

Macau, Hong Kong
September 7-9, 2017

6thEuro-Global Conference on Infectious Diseases

Paris, France
September 13-14, 2017

6th Annual Bacteriology and Parasitology Meeting

Singapore
October 30-November 1, 2017

3rd Annual Congress on Rare Diseases and Orphan Drugs


(10 Plenary Forums - 1 Event)
San Antonio, Texas, USA
March 1-2, 2018

5th International congress on Infectious Diseases

Berlin, Germany

Epidemiology of STD & Infectious Diseases Conference Speakers

Recommended Sessions

Related Journals

Are you interested in